Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2008
11/27/2008US20080292563 Inhalable Powder Containing Tiotropium
11/27/2008US20080292558 Colored esmolol concentrate
11/27/2008DE10251709B4 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/27/2008CA2687957A1 Pharmaceutical containing ppar.delta. agonist
11/27/2008CA2687545A1 Agent for stimulating lymphatic drainage
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687154A1 Composition useful for the prevention of the adverse effect due to the use of ppar-gamma agonists
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1995238A2 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (GPCRS)
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1993594A1 Use of caspases for the preparation of medicaments
11/26/2008EP1993580A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction
11/26/2008EP1993522A2 Resveratrol and/or grape leaf extract as i.a. endurance improver, anti-aging agent, muscle strength improver
11/26/2008EP1534707B9 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/26/2008EP1515736B1 Compositions against inflammatory processes
11/26/2008EP1480642B1 Peroxisome proliferator activated receptor modulators
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1419173B1 Peptides that bind to atherosclerotic lesions
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1370572B1 Mitochondrial membrane permeabilization by hiv-1 vpr and methods of screening
11/26/2008EP1365763B1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008EP1328267B1 Method of treating cancer using dithiocarbamate derivatives
11/26/2008EP1234574B1 Hair growth stimulant
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008CN101312729A Treatment of asthma and copd using triple-combination therapy
11/26/2008CN101311181A Aminomethyl-substituted thiazolobenzimidazole derivative
11/26/2008CN101311165A Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
11/26/2008CN101310771A Visual function disorder improving agents
11/26/2008CN101310754A Super high biomass omnipotent ordered high activity polymer biological activity traditional Chinese medicine preparation series
11/26/2008CN101310723A Use of compounds that are effective as selective opiate receptor modulators
11/26/2008CN101310718A Composition containing catechin for reducing weight and blood fat and use thereof
11/26/2008CN100436453C Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436449C Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aid
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/26/2008CN100436420C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
11/26/2008CN100435794C Use of 4-[(4-thiazolyl) phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
11/26/2008CN100435793C Medicament, containing effector of glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
11/26/2008CN100435788C Inhibitor for perioperative blood sugar elevation
11/26/2008CN100435787C Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
11/25/2008US7456294 Hairpin polyamide
11/25/2008US7456291 Use of a vitamin combination for the treatment of primary headaches
11/25/2008US7456283 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456201 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility
11/25/2008US7456198 Useful in the treatment of chronic and acute pain.
11/25/2008US7456183 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide
11/25/2008US7456172 Succinoylamino benzodiazepines as inhibitors of Aβ protein production
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456163 Macrocycles useful in the treatment of alzheimer's disease
11/25/2008US7456159 For delivering therapeutically effective amount of a drug that includes a parent drug and a prodrug; for delivering steroids
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456157 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/25/2008US7456155 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
11/25/2008US7456150 Pulmonary delivery of active fragments of parathyroid hormone
11/25/2008US7455981 Method of detecting broad-spectrum delta-endotoxins
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2414146C Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
11/25/2008CA2361318C Novel nucleosides and oligonucleotide analogues
11/25/2008CA2345354C Antisense modulation of bcl-x expression
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/20/2008WO2008140126A1 Single-stranded cyclic rna, and method for production thereof
11/20/2008WO2008140125A1 Pharmaceutical composition for prevention of peritoneal fibrosis
11/20/2008WO2008140064A1 Nutrient composition for prevention and amelioration of lifestyle-related disease
11/20/2008WO2008140052A1 Prophylactic or therapeutic agent for posterior ocular disease comprising ropinirole or salt thereof as active ingredient
11/20/2008WO2008140051A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/20/2008WO2008140041A1 Novel antiphlogistic-analgesic agent
11/20/2008WO2008140026A1 Novel leukotriene receptor antagonist
11/20/2008WO2008139987A1 G-protein-conjugated receptor agonist
11/20/2008WO2008139952A1 Microtubule-disrupting agent and cancer cell proliferation inhibitor containing the same
11/20/2008WO2008139894A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same
11/20/2008WO2008139879A1 G protein-coupled receptor inhibitor and pharmaceutical product
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008139754A1 2,6-di-tert-butylphenol derivative and melanogenesis inhibitor comprising 2,6-di-tert-butylphenol derivative as the active ingredient
11/20/2008WO2008138214A1 A method for activation and expansion of lymphocytes with high efficiency and the culture sysytem thereof
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008WO2008114017A3 Compositions and methods relating to influenza infection
11/20/2008WO2008097897A9 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1)
11/20/2008US20080289057 Sperm factor sequences
11/20/2008US20080287659 G-CSF Conjugates
11/20/2008US20080287546 Quorum Sensing Modulators
11/20/2008US20080287520 Use of Melatonin in Preventing Postoperative Complications
11/20/2008US20080287502 Transdermal Administration of Proton Pump Inhibitors
11/20/2008US20080287496 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
11/20/2008US20080287483 Polyketides and Their Synthesis and Use
11/20/2008US20080287481 Process for the preparation of desloratadine polymorph mixtures
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287417 Pharmaceutical compositions comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
11/20/2008US20080287413 New crystalline forms
11/20/2008US20080287411 Optically active dihydropyridine derivative
11/20/2008US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group
1 ... 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 ... 1564